Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global Urinalysis market, 2015 2021 (USD Billion)
2.2. Global Urinalysis market : Snapshot
Chapter 3. Urinalysis Market Dynamics
3.1. Introduction
3.2. Market drivers
3.2.1. Global Urinalysis market drivers: Impact analysis
3.2.2. Increasing Aged Population Globally
3.2.3. Increasing Incidences of Target Diseases
3.3. Market restraints
3.3.1. Lack of Healthcare Infrastructure
3.3.2. Strict Government Regulations
3.4. Opportunities
3.4.1. Unmet Clinical Needs in Under Developed Countries
3.5. Porters five forces analysis
3.5.1. Bargaining power of suppliers
3.5.2. Bargaining power of buyers
3.5.3. Threat from new entrants
3.5.4. Threat from new substitutes
3.5.5. Degree of competition
3.6. Market attractiveness analysis
3.6.1. Market attractiveness analysis, by product segment
3.6.2. Market attractiveness analysis, by application segment
3.6.3. Market attractiveness analysis, by regional segment
Chapter 4. Global Urinalysis Market Competitive Landscape
4.1. Company Market Share Analysis
4.1.1. Global Urinalysis market: company market share, 2015
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Product Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research and Development, Product and Regional Expansion
4.3. Price Trend Analysis
4.4. Product Portfolio
4.5. Patent Analysis (2011-2016)
4.5.1. Patent Trend
4.5.2. Patent Share by company
4.5.3. By Region
Chapter 5. Global Urinalysis Market Product Segment Analysis
5.1. Global Urinalysis market: Product overview
5.1.1. Global Urinalysis market revenue share, by product, 2015 and 2021
5.2. Consumables
5.2.1. Global Consumables market, 2015 2021(USD Billion)
5.3. Instruments
5.3.1. Global Instruments market, 2015 2021(USD Billion)
Chapter 6. Global Urinalysis Market Application Segment Analysis
6.1. Global Urinalysis market: Application overview
6.1.1. Global Urinalysis market revenue share, by Application, 2015 and 2020
6.2. Kidney Diseases
6.2.1. Global Urinalysis market for Kidney Diseases, 2015 2021 (USD Billion)
6.3. Hypertension
6.3.1. Global Urinalysis market for Hypertension, 2015 2021(USD Billion)
6.4. Urinary Tract Infection
6.4.1. Global Urinalysis market for Urinary Tract Infection, 2015 2021 (USD Billion)
6.5. Diabetes
6.5.1. Global Urinalysis market for Diabetes, 2015 - 2021(USD Billion)
6.6. Liver Diseases
6.6.1. Global Urinalysis market for Liver Diseases, 2015 - 2021(USD Billion)
6.7. Others
6.7.1. Global Urinalysis market for other Application , 2015 2021 (USD Billion)
Chapter 7. Global Urinalysis Market Regional Segment Analysis
7.1. Global Urinalysis market: Regional overview
7.1.1. Global Urinalysis market revenue share, by region, 2015 and 2021
7.2. North America
7.2.1. North America Urinalysis market revenue, by product, 2015 2021(USD Billion)
7.2.2. North America Urinalysis market revenue, by Application, 2015 2021(USD Billion)
7.2.3. U.S.
7.2.3.1. U.S. Urinalysis market revenue, by product, 2015 2021(USD Billion)
7.2.3.2. U.S. Urinalysis market revenue, by Application, 2015 2021(USD Billion)
7.3. Europe
7.3.1. Europe Urinalysis market revenue, by product, 2015 2021(USD Billion)
7.3.2. Europe Urinalysis market revenue, by Application, 2015 2021(USD Billion)
7.3.3. Germany
7.3.3.1. Germany Urinalysis market revenue, by product, 2015 2021(USD Billion)
7.3.3.2. Germany Urinalysis market revenue, by Application, 2015 2021(USD Billion)
7.3.4. France
7.3.4.1. France Urinalysis market revenue, by product, 2015 2021(USD Billion)
7.3.4.2. France Urinalysis market revenue, by Application, 2015 2021(USD Billion)
7.3.5. UK
7.3.5.1. UK Urinalysis market revenue, by product, 2015 2021(USD Billion)
7.3.5.2. UK Urinalysis market revenue, by Application, 2015 2021(USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Urinalysis market revenue, by product, 2015 2021, (USD Billion)
7.4.2. Asia Pacific Urinalysis market revenue, by Application, 2015 2021, (USD Billion)
7.4.3. China
7.4.3.1. China Urinalysis market revenue, by product, 2015 2021(USD Billion)
7.4.3.2. China Urinalysis market revenue, by Application, 2015 2021(USD Billion)
7.4.4. Japan
7.4.4.1. Japan Urinalysis market revenue, by product, 2015 2021(USD Billion)
7.4.4.2. Japan Urinalysis market revenue, by Application, 2015 2021(USD Billion)
7.4.5. India
7.4.5.1. India Urinalysis market revenue, by product, 2015 2021(USD Billion)
7.4.5.2. India Urinalysis market revenue, by Application, 2015 2021(USD Billion)
7.5. Latin America
7.5.1. Latin America Urinalysis market revenue, by product, 2015 2021(USD Billion)
7.5.2. Latin America Urinalysis market revenue, by Application, 2015 2021(USD Billion)
7.5.3. Brazil
7.5.3.1. Brazil Urinalysis market revenue, by product, 2015 2021(USD Billion)
7.5.3.2. Brazil Urinalysis market revenue, by Application, 2015 2021 (USD Billion)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Urinalysis market revenue, by product, 2015 2021 (USD Billion)
7.6.2. Middle East and Africa Urinalysis market revenue, by Application, 2015 2021(USD Billion)
Chapter 8. Company Profile
8.1. Mindray
8.1.1. Overview
8.1.2. Financials
8.1.3. Product portfolio
8.1.4. Business strategy
8.1.5. Recent developments
8.2. Roche Diagnostics
8.2.1. Overview
8.2.2. Financials
8.2.3. Product portfolio
8.2.4. Business strategy
8.2.5. Recent developments
8.3. Siemens Healthcare
8.3.1. Overview
8.3.2. Financials
8.3.3. Product portfolio
8.3.4. Business strategy
8.3.5. Recent developments
8.4. Sysmex
8.4.1. Overview
8.4.2. Financials
8.4.3. Product portfolio
8.4.4. Business strategy
8.4.5. Recent developments
8.5. ARKRAY Inc.
8.5.1. Overview
8.5.2. Financials
8.5.3. Product portfolio
8.5.4. Business strategy
8.5.5. Recent developments
8.6. Alere Inc.
8.6.1. Overview
8.6.2. Financials
8.6.3. Product portfolio
8.6.4. Business strategy
8.6.5. Recent developments
8.7. ACON Laboratories, Inc.
8.7.1. Overview
8.7.2. Financials
8.7.3. Product portfolio
8.7.4. Business strategy
8.7.5. Recent developments
8.8. Bio-Rad
8.8.1. Overview
8.8.2. Financials
8.8.3. Product portfolio
8.8.4. Business strategy
8.8.5. Recent developments
8.9. Labomed, Inc.
8.9.1. Overview
8.9.2. Financials
8.9.3. Product portfolio
8.9.4. Business strategy
8.9.5. Recent developments
8.10. Teco Diagnostics
8.10.1. Overview
8.10.2. Financials
8.10.3. Product portfolio
8.10.4. Business strategy
8.10.5. Recent developments
8.11. Urit Medical
8.11.1. Overview
8.11.2. Financials
8.11.3. Product portfolio
8.11.4. Business strategy
8.11.5. Recent developments